Skip to main content
Premium Trial:

Request an Annual Quote

Genetic MicroSystems Will Operate from an Expanded Facility

Premium

WOBURN, Mass.--Genetic MicroSystems announced it will begin operating in a new 30,000-square-foot facility here next week. The company, founded in 1997, is developing enabling products for genomics research and drug discovery based on a technology platform that includes proprietary approaches to creating arrays on solid supports, rapidly viewing wide fields with high resolution, and related software consumables. Its first product will be a high-performance, low-cost DNA-array-making instrument featuring high speed, consistent spot size, and high repeatability. The company also said it plans to leverage other aspects of its proprietary technology platform by producing WFMTM systems that can capture digital images of surfaces the size of a microscope slide, with submicron resolution, in times ranging from seconds to minutes. Such systems will drive the widespread use of biochip technology in genomics research, make possible rapid rare event detections for microbiological analyses, and facilitate the implementation of virtually real-time telepathology, the company said.

Filed under

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.